Your browser doesn't support javascript.
loading
Antibody interfaces revealed through structural mining.
Yin, Yizhou; Romei, Matthew G; Sankar, Kannan; Pal, Lipika R; Hoi, Kam Hon; Yang, Yanli; Leonard, Brandon; De Leon Boenig, Gladys; Kumar, Nikit; Matsumoto, Marissa; Payandeh, Jian; Harris, Seth F; Moult, John; Lazar, Greg A.
Afiliação
  • Yin Y; Institute for Bioscience and Biotechnology Research and Department of Cell Biology and Molecular Genetics, University of Maryland College Park, College Park, MD, USA.
  • Romei MG; Department of Antibody Engineering, Genentech Inc., South San Francisco, CA, USA.
  • Sankar K; Department of Antibody Engineering, Genentech Inc., South San Francisco, CA, USA.
  • Pal LR; Institute for Bioscience and Biotechnology Research and Department of Cell Biology and Molecular Genetics, University of Maryland College Park, College Park, MD, USA.
  • Hoi KH; Department of Antibody Engineering, Genentech Inc., South San Francisco, CA, USA.
  • Yang Y; Department of Antibody Engineering, Genentech Inc., South San Francisco, CA, USA.
  • Leonard B; Department of Antibody Engineering, Genentech Inc., South San Francisco, CA, USA.
  • De Leon Boenig G; Department of Structural Biology, Genentech Inc., South San Francisco, CA, USA.
  • Kumar N; Department of Structural Biology, Genentech Inc., South San Francisco, CA, USA.
  • Matsumoto M; Department of Structural Biology, Genentech Inc., South San Francisco, CA, USA.
  • Payandeh J; Department of Structural Biology, Genentech Inc., South San Francisco, CA, USA.
  • Harris SF; Department of Structural Biology, Genentech Inc., South San Francisco, CA, USA.
  • Moult J; Institute for Bioscience and Biotechnology Research and Department of Cell Biology and Molecular Genetics, University of Maryland College Park, College Park, MD, USA.
  • Lazar GA; Department of Antibody Engineering, Genentech Inc., South San Francisco, CA, USA.
Comput Struct Biotechnol J ; 20: 4952-4968, 2022.
Article em En | MEDLINE | ID: mdl-36147680
ABSTRACT
Antibodies are fundamental effectors of humoral immunity, and have become a highly successful class of therapeutics. There is increasing evidence that antibodies utilize transient homotypic interactions to enhance function, and elucidation of such interactions can provide insights into their biology and new opportunities for their optimization as drugs. Yet the transitory nature of weak interactions makes them difficult to investigate. Capitalizing on their rich structural data and high conservation, we have characterized all the ways that antibody fragment antigen-binding (Fab) regions interact crystallographically. This approach led to the discovery of previously unrealized interfaces between antibodies. While diverse interactions exist, ß-sheet dimers and variable-constant elbow dimers are recurrent motifs. Disulfide engineering enabled interactions to be trapped and investigated structurally and functionally, providing experimental validation of the interfaces and illustrating their potential for optimization. This work provides first insight into previously undiscovered oligomeric interactions between antibodies, and enables new opportunities for their biotherapeutic optimization.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article